EVIDENCE FOR A SEXUALLY-TRANSMITTED COFACTOR FOR AIDS-RELATED KAPOSIS-SARCOMA IN A COHORT OF HOMOSEXUAL MEN

被引：57

作者：

ARCHIBALD, CP ^{[1
]}

SCHECHTER, MT ^{[1
]}

LE, TN ^{[1
]}

CRAIB, KJP ^{[1
]}

MONTANER, JSG ^{[1
]}

OSHAUGHNESSY, MV ^{[1
]}

机构：

[1] UNIV BRITISH COLUMBIA,FAC MED,VANCOUVER LYMPHADENOPATHY AIDS STUDY GRP,5804 FAIRVIEW AVE,VANCOUVER V6T 1Z3,BC,CANADA

来源：

EPIDEMIOLOGY | 1992年 / 3卷 / 03期

关键词：

AIDS; HIV; KAPOSIS SARCOMA; COFACTOR; SEXUALLY TRANSMITTED DISEASE;

D O I：

10.1097/00001648-199205000-00004

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We examined factors associated with the subsequent development of AIDS-related Kaposi's sarcoma in a cohort of 353 homosexual men infected with human immunodeficiency virus (HIV). Cumulative incidence curves for the development of Kaposi's sarcoma and opportunistic infection were stratified over a wide range of variables at enrollment, including those related to demographics, sexual behavior, illicit drug use, and medical history. We found no strong associations between any of these variables and the development of opportunistic infection, but two were related to Kaposi's sarcoma: use of nitrite inhalants (relative risk, 2.3; 95% confidence interval, 1.0-5.0) and high numbers of sexual contacts during the period 1978-1982 in the AIDS epidemic centers of San Francisco, Los Angeles, and/or New York (relative risk, 3.5; 95% confidence interval, 1.6-7.6). The latter variables remained independently associated with risk of Kaposi's sarcoma even after multivariate adjustment for a number of classical HIV risk factors. These results are consistent with the hypothesis that Kaposi's sarcoma is caused by a sexually transmitted cofactor that has remained more prevalent in the original epidemic centers. The effect of nitrites could be due to an independent biological mechanism or to enhancement of transmission of the cofactor.

引用

页码：203 / 209

页数：7

共 19 条

[1]

Haverkos H.W., Drotman D.P., Morgan M., Prevalence of Kaposi’s sarcoma among patients with AIDS, N Engl J Med, 312, (1985)

[2]

Des Jarlais D.C., Stonebumer R., Thamos P., Friedman S.R., Declines in proportions of Kaposi’s sarcoma among cases of AIDS in multiple risk groups in New York city, Lancet, 2, pp. 1024-1025, (1987)

[3]

Selik R.M., Starcher E.T., Curran J.W., Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends, AIDS, 1, pp. 175-182, (1987)

[4]

Rutherford G.W., Schwarcz S.K., Lemp G.F., Barnhart J.L., Rauch K.J., Warner W.L., Piland T.H., Werdegar D., The epidemiology of AIDS-related Kaposi’s sarcoma in San Francisco, J Infect Dis, 159, pp. 569-572, (1989)

[5]

Beral V., Peterman T.A., Berkelman R.L., Jaffe H.W., Kaposi’s sarcoma among persons with AIDS: A sexually transmitted infection?, Lancet, 335, pp. 123-127, (1990)

[6]

Couturier E., Ancelle-Park R.A., De Vincenzi I., Downs A.M., Brunet J.B., Kaposi’s sarcoma as a sexually transmitted disease, Lancet, 335, (1990)

[7]

Schechter M.T., Marion S.A., Elmslie K.D., Ricketts M.N., Nault P., Archibald C.P., Geographic and birth cohort associations of Kaposi’s sarcoma among homosexual men in Canada, Am J Epidemiol, 134, pp. 485-488, (1991)

[8]

Beral V., Bull D., Jaffe H., Evans B., Gill N., Tillett H., Swerdlow A.J., Is risk of Kaposi’s sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa?, Br Med J, 302, pp. 624-625, (1991)

[9]

Lifson A.R., Darrow W.W., Hessol N.A., O'Malley P.M., Barnhart J.L., Jaffe H.W., Rutherford G.W., Kaposi’s sarcoma in a cohort of homosexual and bisexual men, Am J Epidemiol, 131, pp. 221-231, (1990)

[10]

Jeffries E., Willoughby B., Boyko W.J., Schechter M.T., Wiggs B., Fay S., O'Shaughnessy M., The Vancouver Lymphadenopathy-AIDS Study. 2. Seroepidemiology of HTLV-III antibody, Can Med Assoc J, 132, pp. 1373-1377, (1985)

← 1 2 →